These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21217359)

  • 1. Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics.
    Brisson D; Méthot J; Tremblay K; Tremblay M; Perron P; Gaudet D
    Pharmacogenet Genomics; 2010 Dec; 20(12):742-7. PubMed ID: 21217359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program.
    Rhodes KS; Weintraub M; Marchlewicz EH; Rubenfire M; Brook RD
    J Clin Lipidol; 2015; 9(4):559-67. PubMed ID: 26228674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
    Gaudet D; Alexander VJ; Baker BF; Brisson D; Tremblay K; Singleton W; Geary RS; Hughes SG; Viney NJ; Graham MJ; Crooke RM; Witztum JL; Brunzell JD; Kastelein JJ
    N Engl J Med; 2015 Jul; 373(5):438-47. PubMed ID: 26222559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertriglyceridemia secondary to obesity and diabetes.
    Subramanian S; Chait A
    Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-rich lipoprotein cholesterol exceeds low-density lipoprotein cholesterol in hypertriglyceridemia patients.
    Ai M; Tanaka A; Tomie N; Ogita K; Sekine M; Numano F; Numano F
    Horm Metab Res; 2001 Oct; 33(10):612-7. PubMed ID: 11607882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?
    Chukwurah MI; Miller M
    Curr Cardiol Rep; 2023 Sep; 25(9):987-992. PubMed ID: 37505399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein cholesterol and triglycerides in the statin era: a pending issue?
    Paillard F
    Arch Cardiovasc Dis; 2009 Mar; 102(3):165-7. PubMed ID: 19375669
    [No Abstract]   [Full Text] [Related]  

  • 11. [Introduction to drug therapy].
    Ishii H; Yoshida M
    Nihon Rinsho; 2013 Sep; 71(9):1636-40. PubMed ID: 24205727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D; Hamood H; Morad N; Naschitz J
    Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
    Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
    Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for severe hypertriglyceridemia treatment, are there new strategies?
    Filippatos TD; Elisaf MS
    Curr Vasc Pharmacol; 2014; 12(4):598-616. PubMed ID: 23627980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
    Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
    Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.
    Endocrine Society
    Am Fam Physician; 2013 Jul; 88(2):142-4. PubMed ID: 23939649
    [No Abstract]   [Full Text] [Related]  

  • 19. [The hypotriglyceridemic effects of polyunsaturated fatty acids: pathogenetic hypothesis].
    Del Ponte A; Bitti G; Di Giacomo G; Marinari S
    Riv Eur Sci Med Farmacol; 1995; 17(5):175-82. PubMed ID: 8766785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
    Pasalić D; Sertić J; Kunović B; Milicević Z; Pasić A; Zrinski-Topić R; Ferencak G; Stavljenić-Rukavina A
    Croat Med J; 2001 Oct; 42(5):517-22. PubMed ID: 11593500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.